Healthcare - Biotechnology - NASDAQ - US
$ 1.245
-17 %
$ 78.9 M
Market Cap
-1.28
P/E
INCOME STATEMENT
5.49 M
REVENUE
-52.1 M
OPERATING INCOME
-50.7 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Cue Biopharma, Inc.
| Revenue | 5.49 M |
| Cost Of Revenue | 38.1 M |
| Gross Profit | -32.6 M |
| Operating Expenses | 19.5 M |
| Operating Income | -52.1 M |
| Other Expenses | -1.42 M |
| Net Income | -50.7 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | |
|---|---|---|---|---|---|---|---|---|---|
| REVENUE | |||||||||
| Revenue | 5.5 | 1.2 | 14.9 | 3.2 | 3.5 | 1.1 | 0 | 0 | 0 |
| GROSS PROFIT | |||||||||
| Cost Of Revenue | 38.1 | 1.8 | (1.8) | 33.5 | 27.5 | 28.5 | 0.4 | 0.2 | 44.8 K |
| Gross Profit | (32.6) | (0.6) | 16.7 | (30.4) | (24.0) | (27.4) | (0.4) | (0.2) | 44.8 K |
| OPERATING INCOME | |||||||||
| Operating Expenses | 19.5 | 54.7 | 58.7 | 48.2 | 40.2 | 39.8 | 23.2 | 7.7 | 1.9 |
| Selling, General and Administrative Expenses | 16.7 | 16.2 | 17.3 | 14.7 | 12.7 | 11.3 | 4.3 | 2.0 | 0.4 |
| Research and Development Expenses | 40.8 | 38.6 | 41.3 | 33.5 | 27.5 | 28.5 | 18.9 | 5.7 | 1.5 |
| Operating Income | (52.1) | (53.2) | (43.7) | (45.0) | (36.8) | (38.7) | (23.2) | (7.7) | (1.9) |
| PRE-TAX INCOME | |||||||||
| Interest Income Expense | 1.2 | 0.7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income | 1.4 | 0.2 | 45.9 K | 0.5 | 0.5 | 0.5 | 35 | 52 | 0 |
| Pre-Tax Income | (50.7) | (53.0) | (43.7) | (44.6) | (36.3) | (38.2) | (23.2) | (7.7) | (1.9) |
| NET INCOME | |||||||||
| Tax Provision | 0 | (0.2) | 0.5 | 0.2 | 0.4 | 0.8 | 0 | 0 | 0 |
| Net Income | (50.7) | (52.8) | (44.2) | (44.8) | (36.7) | (39.0) | (23.2) | (7.7) | (1.9) |
| EPS | 1.11 | 1.48 | 1.41 | 1.56 | 1.66 | 1.94 | 1.13 | 0.37 | 0.0934 |